JP3219833B2 - Method for producing 4-substituted propylazetidin-2-one derivative - Google Patents
Method for producing 4-substituted propylazetidin-2-one derivativeInfo
- Publication number
- JP3219833B2 JP3219833B2 JP10243092A JP10243092A JP3219833B2 JP 3219833 B2 JP3219833 B2 JP 3219833B2 JP 10243092 A JP10243092 A JP 10243092A JP 10243092 A JP10243092 A JP 10243092A JP 3219833 B2 JP3219833 B2 JP 3219833B2
- Authority
- JP
- Japan
- Prior art keywords
- solution
- formula
- chlorocarbonate
- compound
- stirred
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Plural Heterocyclic Compounds (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は4−置換プロピルアゼチ
ジン−2−オン誘導体の製造方法に関し、より詳細に
は、下記式BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing a 4-substituted propylazetidin-2-one derivative.
【0002】[0002]
【化4】 Embedded image
【0003】式中、R1は水酸基の保護基を表わし、R
2は水素原子又はアミノ保護基を表わす、で示される化
合物に、クロル炭酸メチル、クロル炭酸エチル、クロル
炭酸イソブチル、塩化ジフェニルホスホリル、塩化メチ
ルスルホニル、塩化チオニル、無水トリフルオロ酢酸お
よびジシクロヘキシルカルボジイミドからなる群より選
択されるいずれか一種のカルボン酸活性化剤、塩基及び
イミダゾールを反応させ、次いで下記式In the formula, R 1 represents a protecting group for a hydroxyl group;
2 represents a hydrogen atom or an amino-protecting group, a compound represented by the following formula: methyl chlorocarbonate, ethyl chlorocarbonate, chlorocarbonate
Isobutyl carbonate, diphenylphosphoryl chloride, methyl chloride
Rusulfonyl, thionyl chloride, trifluoroacetic anhydride and
And dicyclohexylcarbodiimide
Reacting any one of the selected carboxylic acid activators, base and imidazole, and then reacting with the following formula
【0004】[0004]
【化5】 Mg(O2CCH2CO2R3)2 (II) 式中、R3はカルボキシ保護基を表わす、で示されるマ
グネシウムマロネート化合物を反応させることを特徴と
する下記式(I)Embedded image Mg (O 2 CCH 2 CO 2 R 3 ) 2 (II) wherein R 3 represents a carboxy-protecting group, and a magnesium malonate compound represented by the following formula (I): )
【0005】[0005]
【化6】 Embedded image
【0006】式中、R1、R2及びR3は前記定義のとお
りである、で示される4−置換プロピルアゼチジン−2
−オン誘導体の製造方法に関する。Wherein R 1 , R 2 and R 3 are as defined above, 4-substituted propylazetidine-2
The present invention relates to a method for producing an -one derivative.
【0007】[0007]
【従来の技術と問題点】上記式(I)で示される(3
S,4R)−3−[(1R)−1−置換オキシエチル]
−4−[(1R)−1−メチル−3−置換オキシカルボ
ニル−2−オキソ]プロピルアゼチジン−2−オン誘導
体は、抗菌活性を有する1β−メチルカルバペネム化合
物の重要な合成中間体となり得ることが知られている
(例えば特開昭63−170377号公報)。2. Description of the Related Art (3)
S, 4R) -3-[(1R) -1-substituted oxyethyl]
The 4-[(1R) -1-methyl-3-substituted oxycarbonyl-2-oxo] propylazetidin-2-one derivative can be an important synthetic intermediate of 1β-methylcarbapenem compound having antibacterial activity. Is known (for example, JP-A-63-170377).
【0008】かかる式(I)の化合物は、その1つの方
法として式(III)で示される(3S,4R)−3−
[(1R)−1−置換オキシエチル]−4−[(1R)
−1−カルボキシエチル]アゼチジン−2−オン誘導体
を原料として合成できることが報告されている(ヘテロ
サイクルズ、vol.21、p29(1984))。こ
の方法は、式(III)の化合物にカルボン酸活性化剤
であるカルボニルジイミダゾール及びマグネシウムマロ
ネート化合物を反応させることによって、式(I)の化
合物を得る方法である。The compound of the formula (I) is prepared by a method (3S, 4R) -3- represented by the formula (III).
[(1R) -1-substituted oxyethyl] -4-[(1R)
It has been reported that -1-carboxyethyl] azetidin-2-one derivative can be synthesized as a raw material (Heterocycles, vol. 21, p29 (1984)). In this method, a compound of the formula (I) is obtained by reacting a compound of the formula (III) with a carboxylic acid activator, carbonyldiimidazole and a magnesium malonate compound.
【0009】しかしながら、上記文献記載の方法を工業
的規模で実施しようとすると、試薬として用いられるカ
ルボニルジイミダゾールが高価であり、常温で不安定で
あることから、製造コストの上昇、原料の長期保存が困
難である等の問題が生じる。かかる問題は、式(I)の
化合物を大量に生産しようとする場合に上記方法の重大
な欠点となるものであるが、これまで、この欠点を克服
するための試みは全くなされていないのが現状である。[0009] However, if the method described in the above-mentioned literature is to be carried out on an industrial scale, carbonyldiimidazole used as a reagent is expensive and unstable at ordinary temperature, so that the production cost increases and the raw materials are stored for a long time. Problems such as difficulty in performing Such a problem is a serious drawback of the above-mentioned method when attempting to produce the compound of the formula (I) in large quantities, but until now no attempt has been made to overcome this drawback. It is the current situation.
【0010】[0010]
【問題を解決するための手段】本発明は上記実情に鑑み
なされたものであり、式(III)の化合物を原料とし
て、安価に式(I)の化合物を大量合成することができ
る製造方法を提供するものである。DISCLOSURE OF THE INVENTION The present invention has been made in view of the above circumstances, and provides a method for producing a large amount of a compound of the formula (I) at a low cost using a compound of the formula (III) as a raw material. To provide.
【0011】以下に本発明を詳細に説明するが、理解を
容易ならしめるため、本発明の製造方法を下記模式図の
3工程に分けて説明する。Hereinafter, the present invention will be described in detail. In order to facilitate understanding, the manufacturing method of the present invention will be described by dividing it into three steps shown in the following schematic diagrams.
【0012】[0012]
【化7】 Embedded image
【0013】式中、R1、R2及びR3は前記定義のとお
りである。In the formula, R 1 , R 2 and R 3 are as defined above.
【0014】本明細書において、「低級」なる語は、こ
の語が付された基または化合物の炭素原子数が1〜7
個、好ましくは1〜4個であることを意味する。「低級
アルキル基」は直鎖状または分枝鎖状のいずれであって
もよく、例えばメチル、エチル、n−プロピル、イソプ
ロピル、n−ブチル、イソブチル、sec−ブチル、t
ert−ブチル、n−ペンチル、イソペンチル、n−ヘ
キシル、イソヘキシル基等が包含される。As used herein, the term "lower" refers to a group or compound to which this term is attached having 1 to 7 carbon atoms.
, Preferably 1 to 4. The “lower alkyl group” may be linear or branched, and includes, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl
tert-butyl, n-pentyl, isopentyl, n-hexyl, isohexyl groups and the like.
【0015】さらに「水酸基の保護基」としては例えば
トリメチルシリル、トリエチルシリル、tert−ブチ
ルジメチルシリル、ジフェニル−tert−ブチルシリ
ル等のシリル基、ベンジルオキシカルボニル、p−ニト
ロベンジルオキシカルボニル、o−ニトロベンジルオキ
シカルボニル等の置換または未置換のベンジルオキシカ
ルボニル基、その他通常使用される水酸基の保護基が包
含される。Further, as the "protecting group for hydroxyl group", for example, silyl groups such as trimethylsilyl, triethylsilyl, tert-butyldimethylsilyl, diphenyl-tert-butylsilyl, benzyloxycarbonyl, p-nitrobenzyloxycarbonyl, o-nitrobenzyloxy It includes a substituted or unsubstituted benzyloxycarbonyl group such as carbonyl, and other commonly used hydroxyl-protecting groups.
【0016】さらに「アミノ保護基」は、ペプチド化学
の分野においてアミノ基の保護基としてそれ自体既知の
任意の保護基であることができ、例えば、芳香族アシ
ル基:例えば、フタロイル;ベンゾイル、またはクロロ
ベンゾイル、p−ニトロベンゾイル、p−tert−ブ
チルベンゾイル、トルオイルなどのハロゲン、ニトロも
しくは低級アルキルで置換されたベンゾイル;ナフトイ
ル;フェニルアセチル;フェノキシアセチル;ベンゼン
スルホニル、p−tert−ブチルベンゼンスルホニ
ル、トルエンスルホニルなどの低級アルキル置換ベンゼ
ンスルホニル等、脂肪族またはハロゲン化脂肪族カル
ボン酸アシル基:例えば、カンフアスルホニル、メタン
スルホニル、ホルミル、アセチル、バレリル、カプリリ
ル、n−デカノイル、アクリロイル、ピバロイル、ハロ
ゲノアセチル(例、モノクロロアセチル、モノブロモア
セチル、ジクロロアセチル、トリクロロアセチル)等、
エステル化されたカルボキシ基:例えば、エトキシカ
ルボニル、tert−ブチルオキシカルボニル、アリル
オキシカルボニル、イソボルニルオキシカルボニル、フ
ェニルオキシカルボニル、トリクロロエトキシカルボニ
ル、ベンジルオキシカルボニル、p−ニトロベンジルオ
キシカルボニル等、カルバモイルまたはチオカルバモ
イル基:例えば、メチルカルバモイル、フェニルカルバ
モイル、ナフチルカルバモイル等もしくはこれらに対応
するチオカルバモイル基等が挙げられる。Further, the "amino protecting group" can be any protecting group known per se as a protecting group for an amino group in the field of peptide chemistry, for example, an aromatic acyl group: for example, phthaloyl; benzoyl, or Benzoyl substituted by halogen, nitro or lower alkyl such as chlorobenzoyl, p-nitrobenzoyl, p-tert-butylbenzoyl, toluoyl; naphthoyl; phenylacetyl; phenoxyacetyl; benzenesulfonyl, p-tert-butylbenzenesulfonyl, toluene Aliphatic or halogenated aliphatic carboxylic acid acyl groups such as lower alkyl-substituted benzenesulfonyl such as sulfonyl: for example, camphorsulfonyl, methanesulfonyl, formyl, acetyl, valeryl, caprylyl, n-decanoyl, Liloyl, pivaloyl, halogenoacetyl (eg, monochloroacetyl, monobromoacetyl, dichloroacetyl, trichloroacetyl), etc.
Esterified carboxy group: for example, carbamoyl or ethoxycarbonyl, tert-butyloxycarbonyl, allyloxycarbonyl, isobornyloxycarbonyl, phenyloxycarbonyl, trichloroethoxycarbonyl, benzyloxycarbonyl, p-nitrobenzyloxycarbonyl, etc. Thiocarbamoyl group: For example, methylcarbamoyl, phenylcarbamoyl, naphthylcarbamoyl and the like or a thiocarbamoyl group corresponding thereto and the like.
【0017】「カルボキシ保護基」としては例えばエス
テル残基を例示することができ、かかるエステル残基と
してはメチル、エチル、n−プロピル、イソプロピル、
n−、iso−、sec−、tert−ブチル、n−ヘ
キシルエステル等の低級アルキルエステル残基;ベンジ
ル、p−ニトロベンジル、o−ニトロベンジル、p−メ
トキシベンジル等のアラルキルエステル残基;アセトキ
シメチル、プロピオニルオキシメチル、n−、iso
−、ブチリルオキシメチル、ピバロイルオキシメチル等
の低級脂肪族アシルオキシメチル残基等が包含される。Examples of the "carboxy-protecting group" include, for example, ester residues, such as methyl, ethyl, n-propyl, isopropyl, and the like.
lower alkyl ester residues such as n-, iso-, sec-, tert-butyl and n-hexyl ester; aralkyl ester residues such as benzyl, p-nitrobenzyl, o-nitrobenzyl and p-methoxybenzyl; acetoxymethyl , Propionyloxymethyl, n-, iso
And lower aliphatic acyloxymethyl residues such as-, butyryloxymethyl and pivaloyloxymethyl.
【0018】以下に、前記模式図の各工程に従って、本
発明を説明する。Hereinafter, the present invention will be described in accordance with each step of the schematic diagram.
【0019】(a)本工程は、不活性有機溶媒中、式
(III)の化合物と塩基、およびカルボン酸活性化剤
(但し、カルボニルジイミダゾールを除く)を反応させ
る工程である。(A) This step is a step of reacting the compound of the formula (III) with a base and a carboxylic acid activator (excluding carbonyldiimidazole) in an inert organic solvent.
【0020】本工程で用いられる不活性有機溶媒として
は、例えばエーテル、テトラヒドロフラン、ジオキサン
等のエーテル系溶媒;トルエン、キシレン、シクロヘキ
サン等の炭化水素系溶媒;ジクロルメタン、クロロホル
ム等のハロゲン化炭化水素系溶媒;酢酸エチル;アセト
ニトリルなどを挙げることができるが、特にアセトニト
リルが好適に使用される。Examples of the inert organic solvent used in this step include ether solvents such as ether, tetrahydrofuran and dioxane; hydrocarbon solvents such as toluene, xylene and cyclohexane; halogenated hydrocarbon solvents such as dichloromethane and chloroform. Ethyl acetate; acetonitrile, etc., and acetonitrile is particularly preferably used.
【0021】塩基としては、例えばトリメチルアミン、
トリエチルアミン、N,N−ジイソプロピル−N−エチ
ルアミン等のトリ(低級)アルキルアミン;例えばピリ
ジン、ピコリン、ルチジン、N,N−ジメチルアミノピ
リジンのようなN,N−ジ(低級)アルキルアミノピリ
ジン等のピリジン化合物;キノリン;例えばN−メチル
モルホリン等のN−(低級)アルキルモルホリン;例え
ばN,N−ジメチルベンジルアミン等のN,N−ジ(低
級)アルキルベンジルアミン等を挙げることができる
が、好ましくは、トリエチルアミン、N,N−ジメチル
アミノピリジン等を用いることができる。塩基の使用量
は使用されるカルボン酸活性化剤の種類によっても異な
るが、通常、式(III)の化合物1モル当り約0.0
5〜約3モル、好ましくは0.08〜2.2モルの割合
で用いるのが適当である。As the base, for example, trimethylamine,
Tri (lower) alkylamines such as triethylamine and N, N-diisopropyl-N-ethylamine; for example, N, N-di (lower) alkylaminopyridines such as pyridine, picoline, lutidine, N, N-dimethylaminopyridine Pyridine compounds; quinolines; N- (lower) alkyl morpholines such as N-methylmorpholine; N, N-di (lower) alkylbenzylamines such as N, N-dimethylbenzylamine; Can be triethylamine, N, N-dimethylaminopyridine or the like. The amount of the base used varies depending on the type of the carboxylic acid activator used, but is usually about 0.03 per mole of the compound of the formula (III).
Suitably, it is used in a proportion of 5 to about 3 mol, preferably 0.08 to 2.2 mol.
【0022】カルボン酸活性化剤としては、カルボニル
ジイミダゾールに比較して安価で、かつ、常温で長期保
存に耐え得るものが好ましく、例えばクロル炭酸メチ
ル、クロル炭酸エチル、クロル炭酸イソブチル等のクロ
ル炭酸アルキル化合物;塩化ジフェニルホスホリル;塩
化メチルスルホニル;塩化チオニル;無水トリフルオロ
酢酸;ジシクロヘキシルカルボジイミドが用いられ、特
にクロル炭酸エチル、クロル炭酸イソブチル等が好まし
い。これらカルボン酸活性化剤の使用量は臨界的でなく
適宜変更することができるが、通常、式(III)の化
合物1モル当り約0.5〜約3モル、好ましくは0.7
〜1.5モルの割合で用いるのが適当である。As the carboxylic acid activator, those which are inexpensive as compared with carbonyldiimidazole and which can withstand long-term storage at room temperature are preferable. For example, chlorocarbonates such as methyl chlorocarbonate, ethyl chlorocarbonate and isobutyl chlorocarbonate are preferable. An alkyl compound; diphenylphosphoryl chloride; methylsulfonyl chloride; thionyl chloride; trifluoroacetic anhydride; dicyclohexylcarbodiimide is used, and ethyl chlorocarbonate and isobutyl chlorocarbonate are particularly preferred. The amount of these carboxylic acid activators to be used is not critical and can be changed as appropriate, but is usually about 0.5 to about 3 mol, preferably 0.7 mol, per mol of the compound of the formula (III).
Suitably, it is used in a proportion of .about.1.5 mol.
【0023】反応は、以下のいずれかの方法、すなわ
ち、 (1)不活性有機溶媒中で、式(III)の化合物に塩
基を加えて撹拌した後、カルボン酸活性化剤を加えて更
に撹拌する方法; (2)不活性有機溶媒中で、カルボン酸活性化剤に塩基
を加えて撹拌した後、式(III)の化合物を加えて更
に撹拌する方法; (3)不活性有機溶媒中で式(III)の化合物に塩基
を加えて撹拌し、得られた反応液を、予めカルボン酸活
性化剤を不活性有機溶媒に溶解して得られた溶液に加え
て、更に撹拌する方法; を実施することによって行なうことができる。The reaction is carried out by any of the following methods: (1) In an inert organic solvent, a base is added to the compound of the formula (III) and stirred, and then a carboxylic acid activator is added and further stirred. (2) A method of adding a base to a carboxylic acid activator in an inert organic solvent and stirring the mixture, then adding a compound of the formula (III) and further stirring the mixture; (3) In an inert organic solvent Adding a base to the compound of the formula (III) and stirring, adding the obtained reaction solution to a solution obtained by previously dissolving a carboxylic acid activator in an inert organic solvent, and further stirring. It can be done by performing.
【0024】添加、及び撹拌の際の温度は、用いられる
カルボン酸活性化剤の種類によって異なるが、上記いず
れの方法を用いる場合でも、一般に、−78℃〜室温程
度の比較的低温であることが好ましい。The temperature at the time of addition and stirring varies depending on the type of the carboxylic acid activator to be used. However, when any of the above methods is used, it is generally a relatively low temperature of -78 ° C. to room temperature. Is preferred.
【0025】また、反応時間は上記いずれの方法を用い
るかによって異なるが、通常、5分間〜4時間程度の範
囲であることができる。The reaction time varies depending on which of the above methods is used, but can usually be in the range of about 5 minutes to 4 hours.
【0026】なお、必須ではないが、本工程において用
いられる溶媒は無水であることが好ましく、また、撹拌
は不活性雰囲気下、例えば窒素ガス、アルゴンカケス雰
囲気下で行なうのが望ましい。Although not essential, the solvent used in this step is preferably anhydrous, and the stirring is desirably performed under an inert atmosphere, for example, a nitrogen gas or argon atmosphere.
【0027】(b)本工程は、上記工程(a)で得られ
た反応液にイミダゾールを加えて撹拌する工程である。(B) This step is a step of adding imidazole to the reaction solution obtained in the above step (a) and stirring the mixture.
【0028】加えられるイミダゾールの量は、特に限定
されず、一般に、式(III)の化合物1モル当り約
0.5〜約3モル、好ましくは0.7〜2.5モルの割合
で用いるのが適当である。The amount of imidazole added is not particularly limited and is generally used in a proportion of about 0.5 to about 3 mol, preferably 0.7 to 2.5 mol, per mol of the compound of the formula (III). Is appropriate.
【0029】添加、及び撹拌の際の温度はカルボン酸活
性化剤の種類によっても異なるが、通常、−78℃〜室
温程度の比較的低温であることが好ましい。The temperature at the time of addition and stirring varies depending on the type of the carboxylic acid activator, but it is usually preferable that the temperature is relatively low at about -78 ° C. to room temperature.
【0030】かかる条件下で、撹拌は一般に、5分間〜
2時間行なうことができる。Under these conditions, stirring is generally from 5 minutes to
Can be performed for 2 hours.
【0031】なお、本工程は、必須ではないが、不活性
雰囲気下、例えば窒素ガス、アルゴンガス雰囲気下で行
なうのが望ましい。This step is not essential, but is preferably performed in an inert atmosphere, for example, a nitrogen gas or argon gas atmosphere.
【0032】(c)本工程は、上記工程(b)で得られ
た反応液に式(II)のマグネシウムマロネート化合物
を加えて反応させ、式(I)の化合物を得る工程であ
る。(C) This step is a step in which a magnesium malonate compound of the formula (II) is added to the reaction solution obtained in the above step (b) and reacted to obtain a compound of the formula (I).
【0033】加えられるマグネシウムマロネート化合物
の量は臨界的でなく適宜変更することができるが、通
常、式(III)の化合物1モル当り約0.5〜約3モ
ル、好ましくは0.7〜2.5モルの割合であることが
適当である。The amount of magnesium malonate compound added is not critical and can be varied as appropriate, but is usually from about 0.5 to about 3 moles, preferably from 0.7 to 3 moles, per mole of compound of formula (III). Suitably a proportion of 2.5 moles.
【0034】反応温度は厳密に制限されるものではない
が、一般に、室温程度〜約100℃、好ましくは約40
℃〜約80℃であることができる。The reaction temperature is not strictly limited, but is generally from about room temperature to about 100 ° C., preferably about 40 ° C.
C. to about 80C.
【0035】かかる条件下で、反応は、一般に、30分
間〜36時間程度で完了する。Under such conditions, the reaction is generally completed in about 30 minutes to 36 hours.
【0036】なお、本反応に使用する前記マグネシウム
マロネート化合物にあっては、次式:The magnesium malonate compound used in this reaction is represented by the following formula:
【0037】[0037]
【化8】HOCOCH2COOR3 式中、R3は前記定義のとおりである、で示されるマロ
ン酸半エステルを使用し、前記不活性有機溶媒中塩基の
存在下に無水塩化マグネシウムと反応させて上記マグネ
シウムマロネート化合物に誘導したのち、単離すること
なく前記工程(b)で得られた反応液に添加して、前記
と同様の条件下で反応させることによっても実施するこ
とができる。この場合におけるマロン酸半エステルの使
用量は、通常塩化マグネシウムの約2モル当量であるこ
とが好ましく、また使用する塩基はトリエチルアミンが
好ましい。HOCOCH 2 COOR 3 wherein R 3 is as defined above, and is reacted with anhydrous magnesium chloride in the presence of a base in the above inert organic solvent. It can also be carried out by deriving the above-mentioned magnesium malonate compound, adding it to the reaction solution obtained in the step (b) without isolation, and reacting it under the same conditions as described above. In this case, the amount of the malonic acid half ester used is usually preferably about 2 molar equivalents of magnesium chloride, and the base used is preferably triethylamine.
【0038】本工程の以上の反応は、必須ではないが、
無水の条件下、不活性雰囲気中、例えば窒素ガス、アル
ゴンガス雰囲気中で行なうことが望ましい。The above reactions in this step are not essential,
It is desirable to carry out the reaction under an anhydrous condition in an inert atmosphere, for example, a nitrogen gas or argon gas atmosphere.
【0039】反応終了後、通常行なわれる処理、精製手
段に付すことによつて、目的とする式(I)の化合物を
単離することができる。After completion of the reaction, the desired compound of formula (I) can be isolated by subjecting it to a treatment or purification procedure usually performed.
【0040】以上の工程に従って本発明を実施すれば、
式(III)の化合物から、容易にかつ収率よく、式
(I)の化合物を製造することができ、特に高価な試
薬、例えばカルボニルジイミダゾールを用いる必要がな
い。かかる点で、本発明は前記した、従来の製造方法
(ヘテロサイクルズ、vol.21、p29(198
4))に比べて工業的製造に適した方法であるというこ
とができる。If the present invention is carried out according to the above steps,
The compound of the formula (I) can be produced easily and in good yield from the compound of the formula (III), and it is not necessary to use particularly expensive reagents such as carbonyldiimidazole. In this regard, the present invention relates to the above-described conventional production method (Heterocycles, vol. 21, p29 (198)
It can be said that the method is more suitable for industrial production than 4)).
【0041】以下、実施例によつて本発明を更に詳細に
説明するが、本発明はこれらの記載によって何ら限定さ
れるものでないことはいうまでもない。Hereinafter, the present invention will be described in more detail with reference to Examples, but it goes without saying that the present invention is not limited by these descriptions.
【0042】また、以下の記載においては、次の略号を
用いることとする。In the following description, the following abbreviations will be used.
【0043】PNB; p−ニトロベンジルPNB; p-nitrobenzyl
【0044】[0044]
実施例1クロル炭酸エチル(1) Example 1 Ethyl chlorocarbonate (1)
【0045】[0045]
【化9】 Embedded image
【0046】化合物(1)1gの無水アセトニトリル1
0ml溶液に、窒素気流中、トリエチルアミン0.46
mlを加えて室温にて5分間撹拌する。この溶液に、氷
冷下クロル炭酸エチル360mgを加えて10分間撹拌
した後イミダゾール271mgを加え、室温に戻して3
0分間撹拌する。一方、マロン酸モノp−ニトロベンジ
ルエステル1.345g及び無水塩化マグネシウム26
8mgの無水アセトニトリル5ml溶液に、窒素気流中
氷冷下トリエチルアミン0.78mlを加え、室温まで
戻して1時間撹拌する。この溶液を上記で得られた反応
液に添加した後、窒素気流中、65℃で2時間撹拌す
る。反応終了後、溶媒を減圧下留去して得られた残渣を
酢酸エチル6.3mlに溶解し、1規定塩酸水溶液、5
%炭酸水素ナトリウム水溶液及び飽和食塩水で順次洗浄
する。得られた溶液を無水硫酸マグネシウムで乾燥した
後溶媒を減圧下留去し、得られた残渣をシリカゲルクロ
マトグラフィーに付して、目的化合物(2)を白色結晶
として1.344g(収率84.8%)得た。Compound (1) 1 g of anhydrous acetonitrile 1
0 ml solution in a nitrogen stream, triethylamine 0.46
Add ml and stir at room temperature for 5 minutes. To this solution, 360 mg of ethyl chlorocarbonate was added under ice-cooling, and the mixture was stirred for 10 minutes. Then, 271 mg of imidazole was added.
Stir for 0 minutes. On the other hand, 1.345 g of malonic acid mono-p-nitrobenzyl ester and anhydrous magnesium chloride 26
To a solution of 8 mg of anhydrous acetonitrile in 5 ml of anhydrous acetonitrile was added 0.78 ml of triethylamine in a stream of nitrogen under ice cooling, and the mixture was returned to room temperature and stirred for 1 hour. After adding this solution to the reaction solution obtained above, the mixture is stirred at 65 ° C. for 2 hours in a nitrogen stream. After completion of the reaction, the solvent was distilled off under reduced pressure, and the obtained residue was dissolved in 6.3 ml of ethyl acetate.
And then washed successively with a 20% aqueous sodium hydrogen carbonate solution and saturated saline. After the obtained solution was dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel chromatography to obtain 1.344 g of the target compound (2) as white crystals (yield 84. 8%).
【0047】1H−NMR(CDCl3)δ:1.25
(3H,d)、1.30(3H,d)、2.90(2H,
m)、3.65(2H,s)、3.83(1H,m)、
4.15(1H,m)、5.27(2H,s)、6.03
(1H,bs)、7.55、8.27(4H,芳香環プロ
トン) 実施例2クロル炭酸エチル(2) 化合物(1)120.6gの無水アセトニトリル1.2l
溶液に、窒素気流中、トリエチルアミン42.5gを加
えて室温にて10分間撹拌する。この溶液に、氷冷下ク
ロル炭酸エチル45.57gを加えて10分間撹拌した
後、イミダゾール32.68gを加え、室温に戻して3
0分間撹拌する。一方、マロン酸モノp−ニトロベンジ
ルエステル162.7g及び無水塩化マグネシウム32.
38gの無水アセトニトリル609ml溶液に、窒素気
流中氷冷下、トリエチルアミン68.82gの無水アセ
トニトリル61ml溶液を加え、室温まで戻して30分
間撹拌する。この溶液を上記で得られた反応液に添加し
た後、窒素気流中、65℃で4時間撹拌する。得られた
反応液を実施例1に記載する方法に準じて処理すること
により、目的化合物(2)を白色結晶として116.9
8g(収率61.2%)得た。 1 H-NMR (CDCl 3 ) δ: 1.25
(3H, d), 1.30 (3H, d), 2.90 (2H,
m), 3.65 (2H, s), 3.83 (1H, m),
4.15 (1H, m), 5.27 (2H, s), 6.03
(1H, bs), 7.55, 8.27 (4H, aromatic ring proton) Example 2 Ethyl chlorocarbonate (2) Compound (1) 120.6 g of anhydrous acetonitrile 1.2 l
42.5 g of triethylamine is added to the solution in a nitrogen stream, and the mixture is stirred at room temperature for 10 minutes. To this solution was added 45.57 g of ethyl chlorocarbonate under ice-cooling, and the mixture was stirred for 10 minutes. Then, 32.68 g of imidazole was added, and the mixture was cooled to room temperature.
Stir for 0 minutes. On the other hand, malonic acid mono p-nitrobenzyl ester 162.7 g and anhydrous magnesium chloride 32.
A solution of 68.82 g of triethylamine in 61 ml of anhydrous acetonitrile was added to 38 g of anhydrous acetonitrile 609 ml of the solution in a nitrogen stream under ice cooling, and the mixture was returned to room temperature and stirred for 30 minutes. After adding this solution to the reaction solution obtained above, the mixture is stirred at 65 ° C. for 4 hours in a nitrogen stream. The obtained reaction solution was treated according to the method described in Example 1 to obtain 116.9 of the target compound (2) as white crystals.
8 g (61.2% yield) were obtained.
【0048】本品のNMRスペクトルは、実施例1で得
られたものと完全に一致した。The NMR spectrum of this product was completely consistent with that obtained in Example 1.
【0049】実施例3クロル炭酸エチル(3) クロル炭酸エチル26.04gの無水アセトニトリル4
57ml溶液を約−5℃まで冷却し、この溶液にトリエ
チルアミン26.31gの無水アセトニトリル152m
l溶液を52分間で滴下し、更に同温度にて30分間撹
拌する。得られる反応液に、窒素気流中同温度にて、化
合物(1)60.3gを加えて30分間撹拌し、次い
で、イミダゾール19.07gを加え、室温に戻した後
30分間撹拌する。一方、マロン酸モノp−ニトロベン
ジルエステル81.33g及び無水塩化マグネシウム1
6.18gの無水アセトニトリル457ml溶液に、窒
素気流中氷冷下、トリエチルアミン34.41gの無水
アセトニトリル30.5ml溶液を加え、室温に戻した
後30分間撹拌する。この溶液を上記で得られた反応液
に添加した後、窒素気流中、65℃で3時間撹拌する。
得られた反応液を実施例1に記載する方法に準じて処理
することにより、目的化合物(2)を白色結晶として8
3.08g(収率86.8%)得た。Example 3 Ethyl chlorocarbonate (3) 26.04 g of ethyl chlorocarbonate anhydrous acetonitrile 4
The 57 ml solution was cooled to about -5 DEG C. and 26.31 g of triethylamine in 152 ml of anhydrous acetonitrile were added.
The solution is added dropwise over 52 minutes, and the mixture is further stirred at the same temperature for 30 minutes. 60.3 g of compound (1) is added to the obtained reaction solution at the same temperature in a stream of nitrogen, and the mixture is stirred for 30 minutes. Then, 19.07 g of imidazole is added, and the mixture is returned to room temperature and stirred for 30 minutes. On the other hand, 81.33 g of malonic acid mono-p-nitrobenzyl ester and anhydrous magnesium chloride 1
A solution of 34.41 g of triethylamine in 30.5 ml of anhydrous acetonitrile is added to a solution of 6.18 g of anhydrous acetonitrile in 457 ml of nitrogen under ice-cooling in a nitrogen stream, and the mixture is returned to room temperature and stirred for 30 minutes. After adding this solution to the reaction solution obtained above, the mixture is stirred at 65 ° C. for 3 hours in a nitrogen stream.
The resulting reaction solution was treated according to the method described in Example 1 to obtain the target compound (2) as white crystals.
3.08 g (86.8% yield) was obtained.
【0050】本品のNMRスペクトルは、実施例1で得
られたものと完全に一致した。The NMR spectrum of this product completely coincided with that obtained in Example 1.
【0051】実施例4クロル炭酸エチル(4) 化合物(1)180.9gの無水アセトニトリル457
ml溶液に、窒素気流中室温下、トリエチルアミン7
8.94gを加えて20分間撹拌する。得られる反応液
を、−19℃まで冷却したクロル炭酸エチル78.12
gの無水アセトニトリル1370ml溶液に45分間で
滴下し、同温度にて30分間撹拌する。得られる反応液
に、氷冷下、イミダゾール57.19gを加えた後、室
温まで戻しながら30分間撹拌する。一方、マロン酸モ
ノp−ニトロベンジルエステル244g及び無水塩化マ
グネシウム48.6gの無水アセトニトリル1370m
l溶液に、窒素気流中氷冷下、トリエチルアミン10
3.2gの無水アセトニトリル91ml溶液を加え、室
温に戻して後30分間撹拌する。この溶液を上記で得ら
れた反応液に添加した後、窒素気流中、65℃で3時間
撹拌する。得られた反応液を実施例1に記載する方法に
準じて処理することにより、目的化合物(2)を白色結
晶として258.2g(収率89.9%)得た。Example 4 Ethyl chlorocarbonate (4) Compound (1) 180.9 g of anhydrous acetonitrile 457
ml of triethylamine in a nitrogen stream at room temperature.
Add 8.94 g and stir for 20 minutes. The resulting reaction solution was cooled to −19 ° C. and ethyl chlorocarbonate was 78.12.
g in 1370 ml of anhydrous acetonitrile was added dropwise over 45 minutes and stirred at the same temperature for 30 minutes. 57.19 g of imidazole is added to the obtained reaction solution under ice cooling, and the mixture is stirred for 30 minutes while returning to room temperature. On the other hand, 244 g of malonic acid mono p-nitrobenzyl ester and 48.6 g of anhydrous magnesium chloride were added to 1370 m of anhydrous acetonitrile.
1 solution of triethylamine 10 under ice cooling in a nitrogen stream.
A solution of 3.2 g of 91 ml of anhydrous acetonitrile is added, and the mixture is returned to room temperature and stirred for 30 minutes. After adding this solution to the reaction solution obtained above, the mixture is stirred at 65 ° C. for 3 hours in a nitrogen stream. The resulting reaction solution was treated according to the method described in Example 1 to obtain 258.2 g (yield: 89.9%) of the target compound (2) as white crystals.
【0052】本品のNMRスペクトルは、実施例1で得
られたものと完全に一致した。The NMR spectrum of the product completely matched the one obtained in Example 1.
【0053】実施例5クロル炭酸エチル(5) 化合物(1)361.8gの無水アセトニトリル915
ml溶液に、窒素気流中室温下、トリエチルアミン15
7.9gを加えて室温にて20分間撹拌する。得られる
反応液を、−25℃まで冷却したクロル炭酸エチル15
6.2gの無水アセトニトリル2740ml溶液に62
分間で滴下し、同温度にて35分間撹拌する。得られる
反応液に、同温度で、イミダゾール114.4gを加え
た後、室温まで戻しながら30分間撹拌する。一方、マ
ロン酸モノp−ニトロベンジルエステル488g及び無
水塩化マグネシウム97gの無水アセトニトリル274
1ml溶液に、窒素気流中氷冷下、トリエチルアミン2
06.4gの無水アセトニトリル183ml溶液を加
え、室温まで戻した後1時間撹拌する。この溶液を上記
で得られた反応液に添加した後、窒素気流中、65℃で
2時間半撹拌する。得られた反応液を実施例1に記載す
る方法に準じて処理することにより、目的化合物(2)
を白色結晶として501.9g(収率87.4%)得た。Example 5 Ethyl chlorocarbonate (5) Compound (1) 361.8 g of anhydrous acetonitrile 915
ml of triethylamine in a nitrogen stream at room temperature.
Add 7.9 g and stir at room temperature for 20 minutes. The resulting reaction solution was cooled to −25 ° C. with ethyl chlorocarbonate 15
62 g of a solution of 6.2 g of anhydrous acetonitrile in 2740 ml
And the mixture is stirred at the same temperature for 35 minutes. At the same temperature, 114.4 g of imidazole is added to the resulting reaction solution, and the mixture is stirred for 30 minutes while returning to room temperature. On the other hand, 488 g of malonic acid mono-p-nitrobenzyl ester and 97 g of anhydrous magnesium chloride in anhydrous acetonitrile 274
To a 1 ml solution, triethylamine 2
A solution of 06.4 g of 183 ml of anhydrous acetonitrile was added, and the mixture was returned to room temperature and stirred for 1 hour. After adding this solution to the reaction solution obtained above, the mixture is stirred at 65 ° C. for 2.5 hours in a nitrogen stream. The target compound (2) was obtained by treating the obtained reaction solution according to the method described in Example 1.
Was obtained as white crystals (501.9 g, yield 87.4%).
【0054】本品のNMRスペクトルは、実施例1で得
られたものと完全に一致した。The NMR spectrum of this product completely coincided with that obtained in Example 1.
【0055】実施例6クロル炭酸イソブチル 化合物(1)1gの無水アセトニトリル10ml溶液
に、窒素気流中、トリエチルアミン0.46mlを加え
て室温にて5分間撹拌する。この溶液を−30℃まで冷
却した後、クロル炭酸イソブチル0.50mlを加えて
同条件下で4分間撹拌する。次いで、イミダゾール27
1mgを加えて−30°〜−15℃で15分間撹拌した
後、室温まで戻して更に15分間撹拌する。一方、マロ
ン酸モノp−ニトロベンジルエステル1.345g及び
無水塩化マグネシウム268mgの無水アセトニトリル
5ml溶液に、窒素気流中氷冷下トリエチルアミン0.
78mlを加えた後、室温まで戻して1時間撹拌する。
この溶液を上記で得られた反応液に添加した後、窒素気
流中、65℃で2.5時間撹拌する。反応終了後、溶媒
を減圧下留去して得られた残渣を酢酸エチル6.3ml
に溶解し、1規定塩酸水溶液、5%炭酸水素ナトリウム
水溶液及び飽和食塩水で順次洗浄する。得られた溶液を
無水硫酸マグネシウムで乾燥した後溶媒を減圧下留去
し、得られた残渣をシリカゲルクロマトグラフィーに付
して目的化合物(2)を白色結晶として1.379g
(収率86.9%)得た。Example 6 To a solution of 1 g of isobutyl chlorocarbonate compound (1) in 10 ml of anhydrous acetonitrile was added 0.46 ml of triethylamine in a nitrogen stream, and the mixture was stirred at room temperature for 5 minutes. After the solution was cooled to -30 ° C, 0.50 ml of isobutyl chlorocarbonate was added, and the mixture was stirred for 4 minutes under the same conditions. Then, imidazole 27
After adding 1 mg and stirring at −30 ° to −15 ° C. for 15 minutes, the mixture is returned to room temperature and further stirred for 15 minutes. On the other hand, a solution of 1.345 g of malonic acid mono-p-nitrobenzyl ester and 268 mg of anhydrous magnesium chloride in 5 ml of anhydrous acetonitrile was added with 0.1 ml of triethylamine in a stream of nitrogen under ice cooling.
After adding 78 ml, the mixture is returned to room temperature and stirred for 1 hour.
After adding this solution to the reaction solution obtained above, it is stirred at 65 ° C. for 2.5 hours in a nitrogen stream. After the completion of the reaction, the solvent was distilled off under reduced pressure, and the residue obtained was 6.3 ml of ethyl acetate.
And washed successively with a 1N aqueous hydrochloric acid solution, a 5% aqueous sodium hydrogen carbonate solution and a saturated saline solution. After the obtained solution was dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel chromatography to obtain 1.379 g of the desired compound (2) as white crystals.
(86.9% yield).
【0056】本品のNMRスペクトルは、実施例1で得
られたものと完全に一致した。The NMR spectrum of this product completely coincided with that obtained in Example 1.
【0057】実施例7ジシクロヘキシルカルボジイミド 化合物(1)500mg及びジメチルアミノピリジン2
0mgのアセトニトリル5ml溶液に、氷冷下、窒素気
流中でジシクロヘキシルカルボジイミド376mgを加
えた後、室温まで戻して15分間撹拌する。この溶液に
イミダゾール124mgを加えて更に1時間撹拌する。
一方、マロン酸モノp−ニトロベンジルエステル674
mg及び無水塩化マグネシウム134mgの無水アセト
ニトリル2.5ml溶液に、窒素気流中氷冷下トリエチ
ルアミン0.39mlを加えた後、室温まで戻して1時
間撹拌する。この溶液を上記で得られた反応液に添加し
た後、窒素気流中、60℃で2時間撹拌する。反応終了
後、溶媒を減圧下留去して得られた残渣を酢酸エチル
3.2mlに溶解し、不溶物を濾去して得られた溶液を
1規定塩酸水溶液、5%炭酸水素ナトリウム水溶液及び
飽和食塩水で順次洗浄する。得られた溶液を無水硫酸マ
グネシウムで乾燥した後溶媒を減圧下留去し、得られた
残渣をシリカゲルクロマトグラフィーに付して、目的化
合物(2)を白色結晶として573mg(収率72.2
4%)得た。Example 7 Dicyclohexylcarbodiimide compound (1) 500 mg and dimethylaminopyridine 2
After adding 376 mg of dicyclohexylcarbodiimide to a 5 mg solution of acetonitrile in a nitrogen stream under ice-cooling, the mixture is returned to room temperature and stirred for 15 minutes. 124 mg of imidazole is added to this solution and stirred for another hour.
On the other hand, malonic acid mono p-nitrobenzyl ester 674
To a solution of mg and 134 mg of anhydrous magnesium chloride in 2.5 ml of anhydrous acetonitrile was added 0.39 ml of triethylamine under ice-cooling in a nitrogen stream, and the mixture was returned to room temperature and stirred for 1 hour. After this solution is added to the reaction solution obtained above, the mixture is stirred at 60 ° C. for 2 hours in a nitrogen stream. After completion of the reaction, the solvent was distilled off under reduced pressure, the residue obtained was dissolved in 3.2 ml of ethyl acetate, and the solution obtained by filtering off the insoluble matter was filtered to give a 1N aqueous solution of hydrochloric acid, a 5% aqueous solution of sodium hydrogen carbonate and Wash sequentially with saturated saline. After the obtained solution was dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel chromatography to obtain 573 mg of the target compound (2) as white crystals (yield: 72.2).
4%).
【0058】本品のNMRスペクトルは、前記実施例1
で得られたものと完全に一致した。 実施例8塩化チオニル 化合物(1)500mgの無水アセトニトリル5ml溶
液を−30℃まで冷却し、トリエチルアミン0.23m
l及び塩化チオニル0.17mlを添加して、窒素気流
中、同温度で20分間撹拌する。次いで、イミダゾール
113mg及びトリエチルアミン0.23mlを加えて
更に24時間撹拌する。一方、マロン酸モノp−ニトロ
ベンジルエステル674mg及び無水塩化マグネシウム
134mgの無水アセトニトリル2.5ml溶液に、窒
素気流中氷冷下トリエチルアミン0.39mlを加えた
後、室温まで戻して1時間撹拌する。この溶液を上記で
得られた反応液に添加した後、窒素気流中、60℃で
2.5時間撹拌する。反応終了後、溶媒を減圧下留去し
て得られた残渣を酢酸エチル3.2mlに溶解し、1規
定塩酸水溶液、5%炭酸水素ナトリウム水溶液及び飽和
食塩水で順次洗浄する。得られた溶液を無水硫酸マグネ
シウムで乾燥した後溶媒を減圧下留去し、得られた残渣
をシリカゲルクロマトグラフィーに付して、目的化合物
(2)を白色結晶として496mg(収率62.6%)
得た。The NMR spectrum of this product was determined according to Example 1 above.
Completely matched with those obtained in. Example 8 A solution of 500 mg of the thionyl chloride compound (1) in 5 ml of anhydrous acetonitrile was cooled to -30 ° C, and 0.23 m of triethylamine was cooled.
and 0.17 ml of thionyl chloride are added, and the mixture is stirred at the same temperature for 20 minutes in a nitrogen stream. Then, 113 mg of imidazole and 0.23 ml of triethylamine are added, and the mixture is further stirred for 24 hours. On the other hand, 0.39 ml of triethylamine was added to a solution of 674 mg of malonic acid mono-p-nitrobenzyl ester and 134 mg of anhydrous magnesium chloride in 2.5 ml of anhydrous acetonitrile under ice-cooling in a nitrogen stream, and the mixture was returned to room temperature and stirred for 1 hour. After adding this solution to the reaction solution obtained above, the mixture is stirred at 60 ° C. for 2.5 hours in a nitrogen stream. After completion of the reaction, the solvent was distilled off under reduced pressure, and the residue obtained was dissolved in 3.2 ml of ethyl acetate, and washed successively with a 1N aqueous hydrochloric acid solution, a 5% aqueous sodium hydrogen carbonate solution and a saturated saline solution. After the obtained solution was dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel chromatography to give 496 mg of the target compound (2) as white crystals (62.6% yield). )
Obtained.
【0059】本品のNMRスペクトルは、実施例1で得
られたものと完全に一致した。The NMR spectrum of this product completely coincided with that obtained in Example 1.
【0060】実施例9塩化メチルスルホニル、塩化ジフェニルホスホリル、無
水トリフルオロ酢酸 上記実施例4に記載した方法に従って、塩化メチルスル
ホニル、塩化ジフェニルホスホリル及び無水トリフルオ
ロ酢酸を用いて反応を行ない、それぞれ55.0%、5
1.3%、38.0%の収率で目的化合物(2)を得た。Example 9 Methylsulfonyl chloride, diphenylphosphoryl chloride,
Aqueous trifluoroacetic acid The reaction was carried out using methylsulfonyl chloride, diphenylphosphoryl chloride and trifluoroacetic anhydride according to the method described in Example 4 above.
The target compound (2) was obtained at a yield of 1.3% and 38.0%.
Claims (2)
チル、クロル炭酸イソブチル、塩化ジフェニルホスホリ
ル、塩化メチルスルホニル、塩化チオニル、無水トリフ
ルオロ酢酸およびジシクロヘキシルカルボジイミドから
なる群より選択されるいずれか一種のカルボン酸活性化
剤、塩基及びイミダゾールを反応させ、次いで下記式 【化2】 Mg(O2CCH2CO2R3)2 (II) 式中、R3はカルボキシ保護基を表わす、 で示されるマグネシウムマロネート化合物を反応させる
ことを特徴とする下記式(I) 【化3】 式中、R1、R2及びR3は前記定義のとおりである、 で示される4−置換プロピルアゼチジン−2−オン誘導
体の製造方法。[Claim 1] The following formula: In the formula, R 1 represents a protecting group for a hydroxyl group, the R 2 represents a hydrogen atom or an amino protecting group, in the compounds represented, methyl chlorocarbonate, chlorocarbonate et
Chill, isobutyl chlorocarbonate, diphenyl phosphoryl chloride
, Methylsulfonyl chloride, thionyl chloride, anhydrous trif
From fluoroacetic acid and dicyclohexylcarbodiimide
Any one of the carboxylic acid activating agent selected from the group consisting, of a base and imidazole are reacted, then the following formula: 2] Mg (O 2 CCH 2 CO 2 R 3) in 2 (II) formula, R 3 Represents a carboxy-protecting group, and is reacted with a magnesium malonate compound represented by the following formula (I): In the formula, R 1 , R 2 and R 3 are as defined above, A method for producing a 4-substituted propylazetidin-2-one derivative represented by:
ル、クロル炭酸エチル、クロル炭酸イソブチル、塩化ジ
フェニルホスホリル、塩化メチルスルホニル、塩化チオ
ニル、無水トリフルオロ酢酸、ジシクロヘキシルカルボ
ジイミドのいずれか1つである請求項1記載の製造方
法。2. The carboxylic acid activator is one of methyl chlorocarbonate, ethyl chlorocarbonate, isobutyl chlorocarbonate, diphenylphosphoryl chloride, methylsulfonyl chloride, thionyl chloride, trifluoroacetic anhydride, and dicyclohexylcarbodiimide. 2. The production method according to 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10243092A JP3219833B2 (en) | 1991-03-30 | 1992-03-30 | Method for producing 4-substituted propylazetidin-2-one derivative |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3-122004 | 1991-03-30 | ||
| JP12200491 | 1991-03-30 | ||
| JP10243092A JP3219833B2 (en) | 1991-03-30 | 1992-03-30 | Method for producing 4-substituted propylazetidin-2-one derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH05201967A JPH05201967A (en) | 1993-08-10 |
| JP3219833B2 true JP3219833B2 (en) | 2001-10-15 |
Family
ID=26443147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10243092A Expired - Lifetime JP3219833B2 (en) | 1991-03-30 | 1992-03-30 | Method for producing 4-substituted propylazetidin-2-one derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3219833B2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005033120A1 (en) * | 2003-10-02 | 2005-04-14 | Takasago International Corporation | Method for producing carbapenem derivative |
| WO2011048583A1 (en) | 2009-10-23 | 2011-04-28 | Ranbaxy Laboratories Limited | Process for the preparation of carbapenem compounds |
| US8841444B2 (en) | 2008-07-30 | 2014-09-23 | Ranbaxy Laboratories Limited | Process for the preparation of carbapenem compounds |
-
1992
- 1992-03-30 JP JP10243092A patent/JP3219833B2/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005033120A1 (en) * | 2003-10-02 | 2005-04-14 | Takasago International Corporation | Method for producing carbapenem derivative |
| US8841444B2 (en) | 2008-07-30 | 2014-09-23 | Ranbaxy Laboratories Limited | Process for the preparation of carbapenem compounds |
| WO2011048583A1 (en) | 2009-10-23 | 2011-04-28 | Ranbaxy Laboratories Limited | Process for the preparation of carbapenem compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05201967A (en) | 1993-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2004035540A1 (en) | Malonic acid monoester and method for producing the same | |
| JPH0368027B2 (en) | ||
| JP2708117B2 (en) | Method for synthesizing N-acyl auxiliary | |
| JP3219833B2 (en) | Method for producing 4-substituted propylazetidin-2-one derivative | |
| JPH03178980A (en) | Production of 3-substituted thio-3-cephem compound | |
| SU499812A3 (en) | The method of obtaining derivatives of cephalosporin | |
| CN101500992A (en) | Process for preparing intermediates for the preparation of 1-methylcarbapenem | |
| JP4283913B2 (en) | Process for producing 4-substituted azetidinylpentanoic acid derivatives | |
| JP3467265B2 (en) | Crystals of azetidinone compounds | |
| JPH06340622A (en) | Production of benzylsuccinic acid derivative and intermediate for its synthesis | |
| JP3614175B2 (en) | Method for producing carbapenem compounds | |
| US3868364A (en) | Improved process for producing penicillin compound | |
| JP3238512B2 (en) | Method for producing sulfamides | |
| JPH08311092A (en) | Production of azetidinone compound | |
| JP3209679B2 (en) | Disulfide compound and method for producing the same | |
| JPH0317057A (en) | New 5-membered ring heterocyclic compound | |
| JP2945155B2 (en) | Method for producing acrylic acid derivative | |
| JPH0288578A (en) | Production or carbapenem compound | |
| US4035362A (en) | Methods for preparing cephalosporins | |
| JPH08325261A (en) | Production of azetidinone compound | |
| JPH05500210A (en) | How to make penem | |
| JP3921712B2 (en) | Depsipeptide derivative intermediate and process for producing the same | |
| JP2733256B2 (en) | 4-mercaptopyrazolidine derivative | |
| KR880001760B1 (en) | Process for preparing intermediate products for the preparation of cepharosporins | |
| JPH0118916B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080810 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080810 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090810 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090810 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100810 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100810 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100810 Year of fee payment: 9 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100810 Year of fee payment: 9 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110810 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110810 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120810 Year of fee payment: 11 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120810 Year of fee payment: 11 |